Why Compugen Shares Are Trading Higher By Over 200%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

Shares of Compugen Ltd. (NASDAQ:CGEN) shares rose sharply during Tuesday’s session after Gilead announced an agreement with the company to exclusively license its novel pre-clinical immunotherapy program.

Compugen shares jumped 204.1% to $2.22 on Tuesday.

Here are some other stocks moving in today's mid-day session.

Gainers

• Intelligent Bio Solutions Inc. (NASDAQ:INBS) gained 73% to $0.4853. Intelligent Bio Solutions received National Association of Testing Authorities accreditation for its Intelligent Fingerprinting Drug Screening Solution.
• Panbela Therapeutics, Inc. (NASDAQ:PBLA) shares surged 64% to $1.6601. Panbela Therapeutics shares jumped 120% on Monday after US WorldMeds received FDA approval of eflornithine.
• Jin Medical International Ltd.(NASDAQ:ZJYL) climbed 49.2% to $151.96 after jumping around 264% on Monday.
• ProSomnus, Inc. (NASDAQ:OSA) gained 27.6% to $0.8017. ProSomnus announced data published by Cureus Journal of Medical Science showed successful treatment of obstructive sleep apnea with prosomnus precision oral appliance devices.
• Infobird Co., Ltd (NASDAQ:IFBD) shares gained 27.4% to $1.7266 after the company inked a new business cooperation in software development of information technology system.
• MIND Technology, Inc. (NASDAQ:MIND) rose 23.1% to $5.86.
• Yoshiharu Global Co. (NASDAQ:YOSH) rose 21.1% to $6.20.
• Optex Systems Holdings, Inc (NASDAQ:OPXS) gained 18.2% to $4.86.
• Sunnova Energy International Inc. (NASDAQ:NOVA) jumped 16.3% to $15.32. Piper Sandler upgraded Sunnova Energy Intl from Neutral to Overweight and raised the price target from $13 to $26.
• Cipher Mining Inc. (NASDAQ:CIFR) rose 16% to $3.6450.
• LogicMark, Inc. (NASDAQ:LGMK) gained 15.7% to $1.0650.
• Checkpoint Therapeutics, Inc. (NASDAQ:CKPT) climbed 13.8% to $2.0825. HC Wainwright & Co. reiterated Checkpoint Therapeutics with a Buy and maintained a $34 price target.
• Affirm Holdings, Inc. (NASDAQ:AFRM) gained 13.6% to $49.64 after the company announced it has expanded its services to self-checkout at Walmart stores.
• PureCycle Technologies, Inc. (NASDAQ:PCT) gained 13.2% to $3.17. Roth MKM downgraded PureCycle Technologies from Buy to Neutral and lowered the price target from $6 to $3.
• bioAffinity Technologies, Inc. (NASDAQ:BIAF) rose 12.2% to $1.57.
• Sunrun Inc. (NASDAQ:RUN) gained 9.4% to $19.72 after Piper Sandler upgraded the stock from Neutral to Overweight and raised its price target from $15 to $31.
• Chewy, Inc. (NYSE:CHWY) rose 7.1% to $23.22. Jefferies initiated coverage on Chewy with a Buy rating and announced a price target of $27.
• Marathon Digital Holdings, Inc. (NASDAQ:MARA) gained 6% to $21.09. Marathon Digital entered into a definitive agreement Tuesday to acquire two Bitcoin mining sites for $178.6 million.

Losers

• BYND Cannasoft Enterprises Inc. (NASDAQ:BCAN) fell 49.3% to $0.3501 after the company reported pricing of $1.5 million registered direct offering.
• Motus GI Holdings, Inc. (NASDAQ:MOTS) shares fell 45.6% to $1.17 after the company priced its $5 million public offering.
• CureVac N.V. (NASDAQ:CVAC) declined 35.7% to $3.7384. CureVac announced decision of German Federal Patent Court in broad patent litigation with BioNTech SE.
• ETAO International Co., Ltd. (NASDAQ:ETAO) fell 34.7% to $0.3001. ETAO International received a staff determination letter, on Dec. 13, 2023, from the Listing Qualifications Department of The Nasdaq Stock Market LLC.
• Shengfeng Development Limited (NASDAQ:SFWL) declined 32.4% to $3.24.
• Banzai International, Inc. (NASDAQ:BNZI) fell 26.5% to $4.5006.
• Biodexa Pharmaceuticals Plc (NASDAQ:BDRX) declined 20.2% to $2.4150 after the company disclosed the pricing of a public offering.
• AEye, Inc. (NASDAQ:LIDR) fell 18.8% to $0.0820. Representatives of Continental informed AEye that Continental intends to discontinue the parties' joint lidar development program, including any further development of the HRL131 lidar product line.
• Invivyd, Inc. (NASDAQ:IVVD) fell 16.4% to $3.00. Morgan Stanley upgraded Invivyd from Underweight to Equal-Weight and raised the price target from $1 to $4.
• Biomerica, Inc. (NASDAQ:BMRA) shares fell 16.3% to $1.3798. Biomerica shares gained around 67% on Monday after the company received FDA 510(k) clearance for its Hp Detect ELISA test product.
• BIO-key International, Inc. (NASDAQ:BKYI) declined 16.3% to $0.1461. Following stockholder approval, BIO-Key announced a 1-for-18 reverse stock split to regain compliance with Nasdaq minimum bid price requirement.
• bluebird bio, Inc. (NASDAQ:BLUE) shares fell 14.2% to $2.6180 after the company announced a proposed public offering of $150 million of common stock.
• ZyVersa Therapeutics, Inc. (NASDAQ:ZVSA) fell 14% to $0.92 after surging 38% on Monday.
• Diversified Energy Co PLC (NYSE:DEC) declined 12% to $15.77.
• Alaunos Therapeutics, Inc (NASDAQ:TCRT) fell 10.6% to $0.0513 after jumping 26% on Monday.
• uniQure N.V. (NASDAQ:QURE) fell 9.8% to $7.20 after announcing updated interim data on Phase I/II clinical trials of AMT-130 gene therapy for the treatment of Huntington's disease.
• iCoreConnect Inc. (NASDAQ:ICCT) fell 8.3% to $2.1193 after jumping over 35% on Monday.

Now Read This: How To Earn $500 A Month From General Mills Stock Ahead of Quarterly Earnings Report